Publications in collaboration with researchers from Hospital Universitario Virgen de las Nieves (16)

2022

  1. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  2. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2018

  1. Serial tuberculin skin tests improve the detection of latent tuberculosis infection in patients with inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 12, Núm. 11, pp. 1270-1279

2017

  1. Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

    American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131

2016

  1. Outcomes of medical and surgical therapy for entero-urinary fistulas in Crohn's disease

    Journal of Crohn's and Colitis, Vol. 10, Núm. 6, pp. 657-662

2015

  1. Response to infliximab in Crohn's disease: Genetic analysis supporting expression profile

    Mediators of Inflammation, Vol. 2015

2014

  1. Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab

    Human Immunology, Vol. 75, Núm. 1, pp. 71-75

2013

  1. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease

    Gastroenterology, Vol. 145, Núm. 4

  2. Safety of thiopurines and Anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease

    American Journal of Gastroenterology, Vol. 108, Núm. 3, pp. 433-440

2011

  1. Analysis of the influence of two CD24 genetic variants in Crohn's disease and ulcerative colitis

    Human Immunology, Vol. 72, Núm. 10, pp. 969-972

  2. Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis

    Inflammatory Bowel Diseases, Vol. 17, Núm. 11, pp. 2287-2294

2010

  1. Study of chromosomal region 5p13.1 in Crohn's disease, ulcerative colitis, and rheumatoid arthritis

    Human Immunology, Vol. 71, Núm. 8, pp. 826-828

2009

  1. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease

    American Journal of Gastroenterology, Vol. 104, Núm. 8, pp. 1968-1975

  2. Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15- Crohn's disease patients

    European Journal of Human Genetics, Vol. 17, Núm. 10, pp. 1304-1308

2007

  1. CD209 in inflammatory bowel disease: A case-control study in the Spanish population

    BMC Medical Genetics, Vol. 8

  2. MYO9B polymorphisms in patients with inflammatory bowel disease [3]

    Gut